CN100537556C - 单糖的端基异构衍生物 - Google Patents

单糖的端基异构衍生物 Download PDF

Info

Publication number
CN100537556C
CN100537556C CNB038073757A CN03807375A CN100537556C CN 100537556 C CN100537556 C CN 100537556C CN B038073757 A CNB038073757 A CN B038073757A CN 03807375 A CN03807375 A CN 03807375A CN 100537556 C CN100537556 C CN 100537556C
Authority
CN
China
Prior art keywords
hydrogen
compound
group
alkyl
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CNB038073757A
Other languages
English (en)
Chinese (zh)
Other versions
CN1642932A (zh
Inventor
维姆·莫特曼斯
迈克尔·利奥·韦斯特
江·青丽
乔治·亚当森
卡尔·谢弗
乔瓦尼·阿贝南特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chwast Biotech Pte Ltd
Original Assignee
Alchemia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alchemia Pty Ltd filed Critical Alchemia Pty Ltd
Publication of CN1642932A publication Critical patent/CN1642932A/zh
Application granted granted Critical
Publication of CN100537556C publication Critical patent/CN100537556C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/14Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/12Acyclic radicals, not substituted by cyclic structures attached to a nitrogen atom of the saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
CNB038073757A 2002-03-28 2003-03-28 单糖的端基异构衍生物 Expired - Lifetime CN100537556C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPS1434A AUPS143402A0 (en) 2002-03-28 2002-03-28 Anomeric derivatives of monosaccharides
AUPS1434 2002-03-28

Publications (2)

Publication Number Publication Date
CN1642932A CN1642932A (zh) 2005-07-20
CN100537556C true CN100537556C (zh) 2009-09-09

Family

ID=3835023

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB038073757A Expired - Lifetime CN100537556C (zh) 2002-03-28 2003-03-28 单糖的端基异构衍生物

Country Status (8)

Country Link
US (1) US7737287B2 (enExample)
EP (1) EP1487812A4 (enExample)
JP (1) JP4610197B2 (enExample)
CN (1) CN100537556C (enExample)
AU (1) AUPS143402A0 (enExample)
CA (1) CA2480578C (enExample)
DE (1) DE03745223T1 (enExample)
WO (1) WO2003082846A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7138531B2 (en) 2001-10-15 2006-11-21 Kemin Pharma B.V.B.A. Preparation and use of carbohydrate-based bicyclic ring structures with antimicrobial and cytostatic activity
AU2002950657A0 (en) 2002-08-08 2002-09-12 Alchemia Limited Derivatives of monosaccharides for drug discovery
AU2002951995A0 (en) 2002-10-11 2002-10-31 Alchemia Limited Classes of compounds that interact with gpcrs
US7125854B2 (en) 2003-01-07 2006-10-24 Kemin Pharma B.V.B.A. Bicyclic carbohydrates as antiprotozoal bioactive for the treatment of infections caused by parasites
JP4707397B2 (ja) 2003-01-07 2011-06-22 ケミン・ファーマ・ヨーロッパ・ビー・ブイ・ビー・エイ C型肝炎及びウシウイルス性下痢のウイルスのようなフラビウイルス科に分類される種によって引き起こされる感染の治療に有用な二環式炭水化物化合物
US7368475B2 (en) 2003-03-12 2008-05-06 Kemin Pharma Bvba Furanose-type bicyclic carbohydrates with biological activity
US7098243B2 (en) 2003-09-16 2006-08-29 Kemin Pharma Europe B.V.B.A. Bicyclic carbohydrates as antiviral bioactives for the treatment of infections caused by the alphaherpesvirinae HSV-1 and HSV-2
AU2006209794B2 (en) * 2005-02-04 2010-07-08 Alchemia Limited Classes of compounds that interact with integrins
DE06704810T1 (de) * 2005-02-04 2008-05-21 Alchemia Ltd., Eight Mile Plains Mit integrinen interagierende verbindungsklassen
PL1934388T3 (pl) * 2005-10-04 2013-04-30 Alchemia Ltd Sposób projektowania leków
WO2007070947A1 (en) * 2005-12-22 2007-06-28 Alchemia Ltd Antibacterial agents
WO2021155317A1 (en) 2020-01-31 2021-08-05 Avilar Therapeutics, Inc. Asgpr-binding compounds for the degradation of extracellular proteins
KR20240017423A (ko) 2021-05-03 2024-02-07 아빌라 테라퓨틱스, 인크. 이뮤노글로불린 및 다른 단백질의 분해를 위한 강력한 asgpr-결합 화합물
US12116382B2 (en) 2022-11-28 2024-10-15 Hongene Biotech Corporation Functionalized N-acetylgalactosamine analogs

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998008799A1 (en) * 1996-08-26 1998-03-05 Alchemia Pty. Ltd. Oligosaccharide synthesis

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5331664A (en) * 1976-09-02 1978-03-25 Suami T Production of novel nitroso urea derivatives
DE3347522A1 (de) * 1983-12-30 1985-07-11 Troponwerke GmbH & Co KG, 5000 Köln N-glycosylierte carbonsaeureamid-derivate als mittel bei der bekaempfung von erkrankungen des rheumatischen formenkreises
DE3521994A1 (de) * 1985-06-20 1987-01-02 Bayer Ag N-(2-aminoacylamido-2-desoxy-hexosyl)-amide-, -carbamate und -harnstoffe, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
HU208146B (en) * 1989-11-14 1993-08-30 Biogal Gyogyszergyar Process for producing aminobenzoic acid-n-glycoside derivatives
US5449785A (en) * 1991-07-24 1995-09-12 Hoffmann-La Roche Inc. Cyclohexane derivatives
JPH07242684A (ja) * 1994-03-02 1995-09-19 Japan Tobacco Inc 新規なグルクロン酸化合物
US5491152A (en) * 1994-03-23 1996-02-13 The Du Pont Merck Pharmaceutical Company Derivatives of cyclic ethers and sulfides for the treatment of atherosclerosis
WO1997014709A1 (en) * 1995-10-13 1997-04-24 F. Hoffmann-La Roche Ag Antisense oligomers
JP2002502393A (ja) * 1997-05-29 2002-01-22 インカラ・ファーマシューティカルズ・コーポレーション 炭水化物骨格化合物及びライブラリー
US6197963B1 (en) * 1998-08-13 2001-03-06 The Trustees Of The University Of Pennsylvania Non-peptide peptidomimetics
CA2415368A1 (en) * 2000-07-13 2002-01-31 Yi Jin Synthesis and antiviral evaluation of nucleic acid based (nab) libraries
AUPR079700A0 (en) * 2000-10-17 2000-11-09 Alchemia Pty Ltd Combinatorial libraries of monosaccharides
AUPR084400A0 (en) 2000-10-18 2000-11-09 Alchemia Pty Ltd Immunoadjuvant systems

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998008799A1 (en) * 1996-08-26 1998-03-05 Alchemia Pty. Ltd. Oligosaccharide synthesis

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
'Carbohydrate based mimetics in drug design: sugar aminoacids and carbohydrate scaffolds'. GRUNER S.A.W. ET AL.CHEM. REVIEWS,Vol.102 . 2002 *
'Synthesis of oligomers of tetrahydrofuran amino acids:Furanose carbopeptides'. SMITH ET AL.CHEM. COMMUN.. 1998 *

Also Published As

Publication number Publication date
US7737287B2 (en) 2010-06-15
JP2005526813A (ja) 2005-09-08
WO2003082846A1 (en) 2003-10-09
JP4610197B2 (ja) 2011-01-12
EP1487812A1 (en) 2004-12-22
CN1642932A (zh) 2005-07-20
EP1487812A4 (en) 2006-07-26
CA2480578C (en) 2013-01-08
DE03745223T1 (de) 2007-05-03
AUPS143402A0 (en) 2002-05-09
CA2480578A1 (en) 2003-10-09
US20050245746A1 (en) 2005-11-03

Similar Documents

Publication Publication Date Title
CN100537556C (zh) 单糖的端基异构衍生物
WO2016064082A2 (ko) 신규한 아미노알킬벤조티아제핀 유도체 및 이의 용도
WO2017217792A1 (ko) 다이페닐메탄 유도체의 제조방법
WO2010056022A2 (en) Melanocortin receptor agonists
WO2013048177A2 (ko) 셀레노펜-접합 방향족 화합물, 및 이의 제조 방법
WO2019078522A1 (ko) 세레브론 단백질의 분해 유도 화합물, 이의 제조방법 및 이를 유효성분으로 함유하는 암의 예방 또는 치료용 약학적 조성물
AU2019310508A1 (en) 1,3,4-oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and pharmaceutical composition comprising the same
WO2018066872A1 (ko) 3-페닐-2,3,4,8,9,10-헥사히드로피라노[2,3-f]크로멘 유도체 및 이의 광학 이성질체 합성 방법
WO2018226053A1 (ko) 시클로프로필아민 유도체 화합물 및 이의 용도
WO2016190630A1 (en) Heterocyclicalkyl derivative compounds as selective histone deacetylase inhibitors and pharmaceutical compositions comprising the same
WO2018080127A1 (ko) 아데노신 유도체를 포함하는 비알콜성 지방간염, 간섬유증 및 간경변증 예방 및 치료용 약학적 조성물
WO2014046441A1 (ko) 돌라스타틴 10 유도체, 그의 제조방법 및 그를 포함하는 항암제 조성물
WO2010002115A2 (en) Fxa inhibitors with cyclic amidoxime or cyclic amidrazone as p4 subunit, processes for their preparations, and pharmaceutical compositions and derivatives thereof
WO2016032209A2 (ko) 야누스인산화효소 억제제로서의 치환된 n-(피롤리딘-3-일)-7h-피롤로[2,3-d]피리미딘-4-아민
WO2017119700A1 (ko) 융합 페닐 환이 포함된 c-글루코시드 유도체 또는 이의 약학적으로 허용 가능한 염, 이의 제조방법 및 이를 포함하는 약학적 조성물
WO2012134188A2 (ko) 신규한 옥사졸리디논 유도체 및 이를 함유하는 의약 조성물
WO2021101003A1 (ko) 연속반응 공정에서의 메탄술포닐화 중간체를 이용한 글리플로진 합성 방법
WO2020036382A1 (ko) Sglt 저해제의 합성에 유용한 중간체의 제조
WO2018004202A1 (ko) 다이페닐메탄 유도체의 제조방법
WO2021194228A1 (ko) 암의 예방 또는 치료용 약학적 조성물
WO2018097403A1 (ko) 항암제와 디오스제닌의 컨쥬게이트, 이의 제조방법 및 이를 포함하는 항암용 조성물
WO2020101450A1 (ko) 아질사르탄 유도체 화합물, 이의 중간체, 이의 제조방법 및 이를 포함하는 조성물
WO2017150903A1 (en) Sulfamate derivative compounds, processes for preparing them and their uses
WO2024096408A1 (ko) 아마이드 및 에스터 작용기를 갖는 지질 및 이의 제조방법
WO2024029877A1 (ko) A3 아데노신 수용체 작용제로서의 신규한 퓨린 유도체 화합물

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20150911

Address after: Queensland, Australia

Patentee after: Chwast biotech Pte. Ltd.

Address before: Queensland, Australia

Patentee before: ALCHEMIA LTD.

CX01 Expiry of patent term
CX01 Expiry of patent term

Granted publication date: 20090909